Children's exposure to size-fractioned particulate matter: Chemical composition and internal dose.

The health effects of the particulate matter (PM) depend not only on its aerodynamic diameter (AD) and chemical composition, but also on the time activity pattern of the individuals and on their age. The main objective of this work was to assess the exposure of children to aerosol particles by using personal instruments, to study the particle size and composition of the inhaled PM, and to estimate their transport and deposition into the human respiratory tract (HRT). The average daily PM2.5 exposure was 19 µg/m3 and the size fractions with the greatest contribution to PM2.5 concentrations were 1 < AD <2.5 µm and AD <0.25 µm. Results indicated a contribution of 9% from the mineral aerosol, 7.2% from anthropogenic sulphate, 6.7% from black carbon and 5% from anthropogenic trace elements to the daily exposure to PM2.5. The levels of mineral and marine elements increased with increasing particle size, while anthropogenic elements were present in higher concentrations in the finest particles. Particle size has been shown to influence the variability of daily dose deposited between the extrathoracic and alveolar-interstitial zones. On average, 3% of the PM deposited in the bronchial region, whereas 5% to 8% were found in the bronchiolar region. The level of physical activity had a significant contribution to the total daily dose.

Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST.

In spite of recent advances in describing the health outcomes of exposure to nanoparticles (NPs), it still remains unclear how exactly NPs interact with their cellular targets. Size, surface, mass, geometry, and composition may all play a beneficial role as well as causing toxicity. Concerns of scientists, politicians and the public about potential health hazards associated with NPs need to be answered. With the variety of exposure routes available, there is potential for NPs to reach every organ in the body but we know little about the impact this might have. The main objective of the FP7 NanoTEST project ( www.nanotest-fp7.eu ) was a better understanding of mechanisms of interactions of NPs employed in nanomedicine with cells, tissues and organs and to address critical issues relating to toxicity testing especially with respect to alternatives to tests on animals. Here we describe an approach towards alternative testing strategies for hazard and risk assessment of nanomaterials, highlighting the adaptation of standard methods demanded by the special physicochemical features of nanomaterials and bioavailability studies. The work has assessed a broad range of toxicity tests, cell models and NP types and concentrations taking into account the inherent impact of NP properties and the effects of changes in experimental conditions using well-characterized NPs. The results of the studies have been used to generate recommendations for a suitable and robust testing strategy which can be applied to new medical NPs as they are developed.